These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34785089)

  • 1. Corrigendum to "Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages" [Canc. Lett. 474 (2020) 36-52].
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2022 Jan; 525():200-202. PubMed ID: 34785089
    [No Abstract]   [Full Text] [Related]  

  • 2. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.
    Zhao S; Mi Y; Guan B; Zheng B; Wei P; Gu Y; Zhang Z; Cai S; Xu Y; Li X; He X; Zhong X; Li G; Chen Z; Li D
    J Hematol Oncol; 2020 Nov; 13(1):156. PubMed ID: 33213490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
    Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of CXCL12 Axis in Lung Metastasis of Colorectal Cancer.
    Wang M; Yang X; Wei M; Wang Z
    J Cancer; 2018; 9(21):3898-3903. PubMed ID: 30410593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.
    Beider K; Bitner H; Leiba M; Gutwein O; Koren-Michowitz M; Ostrovsky O; Abraham M; Wald H; Galun E; Peled A; Nagler A
    Oncotarget; 2014 Nov; 5(22):11283-96. PubMed ID: 25526031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C; Lei X; Xiong L; Hu Z; Tang B
    Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7.
    Chatterjee M; von Ungern-Sternberg SN; Seizer P; Schlegel F; Büttcher M; Sindhu NA; Müller S; Mack A; Gawaz M
    Cell Death Dis; 2015 Nov; 6(11):e1989. PubMed ID: 26583329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
    Ou C; Sun Z; Li X; Li X; Ren W; Qin Z; Zhang X; Yuan W; Wang J; Yu W; Zhang S; Peng Q; Yan Q; Xiong W; Li G; Ma J
    Cancer Lett; 2018 Apr; 420():260. PubMed ID: 29429755
    [No Abstract]   [Full Text] [Related]  

  • 11. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.
    Yu X; Wang D; Wang X; Sun S; Zhang Y; Wang S; Miao R; Xu X; Qu X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):32. PubMed ID: 30678736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer" [Canc. Lett. 500 (2021) 119-131].
    Sui Q; Peng J; Han K; Lin J; Zhang R; Ou Q; Qin J; Deng Y; Zhou W; Kong L; Tang J; Xiao B; Li Y; Yu L; Fang Y; Ding PR; Pan Z
    Cancer Lett; 2021 Sep; 516():57-60. PubMed ID: 34091433
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.
    Rigo A; Gottardi M; Zamò A; Mauri P; Bonifacio M; Krampera M; Damiani E; Pizzolo G; Vinante F
    Mol Cancer; 2010 Oct; 9():273. PubMed ID: 20946648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
    Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
    Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
    [No Abstract]   [Full Text] [Related]  

  • 15. JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression.
    Chen H; Li M; Sanchez E; Soof CM; Bujarski S; Ng N; Cao J; Hekmati T; Zahab B; Nosrati JD; Wen M; Wang CS; Tang G; Xu N; Spektor TM; Berenson JR
    Br J Haematol; 2020 Jan; 188(2):283-294. PubMed ID: 31423579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
    Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
    Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.
    Sakai N; Yoshidome H; Shida T; Kimura F; Shimizu H; Ohtsuka M; Takeuchi D; Sakakibara M; Miyazaki M
    Clin Exp Metastasis; 2012 Feb; 29(2):101-10. PubMed ID: 22075627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
    Ma L; Qiao H; He C; Yang Q; Cheung CH; Kanwar JR; Sun X
    Invest New Drugs; 2012 Apr; 30(2):508-17. PubMed ID: 21080209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer" [Canc. Lett. (2022 Apr 28) 532 215585].
    Fu L; Deng R; Huang Y; Yang X; Jiang N; Zhou J; Lin C; Chen S; Wu L; Cui Q; Yun J
    Cancer Lett; 2022 Jul; 539():215696. PubMed ID: 35477591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.